Savara Pharmaceuticals
SVRA
#6301
Rank
C$0.85 B
Marketcap
$5.19
Share price
4.72%
Change (1 day)
10.62%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -C$0.11 B

According to Savara Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -C$0.11 B. In 2023 the company made an earning of -C$75.28 M a decrease over its 2022 earnings that were of -C$52.51 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.11 B35.4%
2023 -C$75.28 M43.38%
2022 -C$52.51 M-11.31%
2021 -C$59.2 M-13.3%
2020 -C$68.28 M-36.53%
2019 -C$0.11 B13.76%
2018 -C$94.57 M105.54%
2017 -C$46.02 M34.11%
2016 -C$34.31 M-37.43%
2015 -C$54.84 M38.81%
2014 -C$39.5 M33.62%
2013 -C$29.57 M38.49%
2012 -C$21.35 M24.59%
2011 -C$17.14 M-36.5%
2010 -C$26.98 M-3.14%
2009 -C$27.86 M-23.28%
2008 -C$36.31 M8.52%
2007 -C$33.46 M-34.14%
2006 -C$50.81 M184.43%
2005 -C$17.87 M90.75%
2004 -C$9.37 M190.35%
2003 -C$3.23 M11.64%
2002 -C$2.89 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$24.99 M-75.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.34 B 224.94%๐Ÿ‡บ๐Ÿ‡ธ USA